flow semaglutide Brendon Neuen on X: "Johannes Mann ending with a plug for the trial, the only dedicated renal outcome trial testing the effect of GLP1-RA ( semaglutide) on a primary outcome of 50% FLOWing with the SemagluTIDE —

Can Ozempic affect my digestion or gut health

And as a result, swift and effective action follows

The top ten factors for employers when considering GLP-1 coverage for weight loss are: Obesity as a risk factor for chronic diseases and associated costs53% Long-term costs and difficulty measuring outcomes38% Impact/effectiveness of cost-control mechanisms on health insurance premiums38% Medication adherence factors25% Immediate/short-term costs25% Broker/consultant/PBM recommendations25% Patient and prescriber demand22% Oral pill forms available22% GLP-1 label expansion/approval for secondary conditions22% Side effects19%

This test does not predict exact medication response or guarantee outcomesinstead, it provides one biological data point among many that inform personalized treatment planning